Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin

Silvio Roncella, Paola Ferro, Maria Cristiana Franceschini, Bartolomeo Bacigalupo, Paolo Dessanti, Massimiliano Sivori, Anna Maria Carletti, Vincenzo Fontana, Pier Aldo Canessa, Maria Pia Pistillo, Franco Fedeli

Research output: Contribution to journalArticle

Abstract

As was reported that human mammaglobin (hMAM) may be expressed in malignant pleural effusions (PEs), we investigated the relevance of hMAM reverse-transcriptase polymerase chain reaction (RT-PCR) for their diagnosis and determination of primary origin. Two hundred and twenty-eight malignant (132 male, 96 female) and 185 benign (132 male, 53 female) PEs were investigated. Statistical analyses evaluated the diagnostic performance parameters in all PEs and in cytologically negative malignant PEs, the association between hMAM and benign or malignant status by the direct index of correlation [diagnostic odds ratio (DOR)], χ test, and P value (P). In addition, the discriminative diagnostic power of hMAM expression, independently in breast cancer, lung cancer (LC), malignant mesothelioma (MM), and other cancers was evaluated. In the entire patient population, hMAM was detected in 45.6% and 5.4% of malignant and benign PEs, respectively, in the male group in 41.7% and 4.5% and in the female group in 51.0% and 7.5% of malignant and benign PEs, respectively. A statistically significant correlation between hMAM and malignancy was found in the entire population (DOR=14.68, P

Original languageEnglish
Pages (from-to)92-98
Number of pages7
JournalDiagnostic Molecular Pathology
Volume19
Issue number2
DOIs
Publication statusPublished - Jun 2010

Fingerprint

Malignant Pleural Effusion
Breast Neoplasms
Pleural Effusion
Lung Neoplasms
Odds Ratio
Reverse Transcriptase Polymerase Chain Reaction
Population
Neoplasms

Keywords

  • Human mammaglobin
  • Malignant pleural effusion
  • Reverse-transcriptase polymerase chain reaction

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Pathology and Forensic Medicine

Cite this

Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin. / Roncella, Silvio; Ferro, Paola; Franceschini, Maria Cristiana; Bacigalupo, Bartolomeo; Dessanti, Paolo; Sivori, Massimiliano; Carletti, Anna Maria; Fontana, Vincenzo; Canessa, Pier Aldo; Pistillo, Maria Pia; Fedeli, Franco.

In: Diagnostic Molecular Pathology, Vol. 19, No. 2, 06.2010, p. 92-98.

Research output: Contribution to journalArticle

Roncella, S, Ferro, P, Franceschini, MC, Bacigalupo, B, Dessanti, P, Sivori, M, Carletti, AM, Fontana, V, Canessa, PA, Pistillo, MP & Fedeli, F 2010, 'Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin', Diagnostic Molecular Pathology, vol. 19, no. 2, pp. 92-98. https://doi.org/10.1097/PDM.0b013e3181ba6c78
Roncella, Silvio ; Ferro, Paola ; Franceschini, Maria Cristiana ; Bacigalupo, Bartolomeo ; Dessanti, Paolo ; Sivori, Massimiliano ; Carletti, Anna Maria ; Fontana, Vincenzo ; Canessa, Pier Aldo ; Pistillo, Maria Pia ; Fedeli, Franco. / Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin. In: Diagnostic Molecular Pathology. 2010 ; Vol. 19, No. 2. pp. 92-98.
@article{4749c8f7cea24035b65b8b632134c6d3,
title = "Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin",
abstract = "As was reported that human mammaglobin (hMAM) may be expressed in malignant pleural effusions (PEs), we investigated the relevance of hMAM reverse-transcriptase polymerase chain reaction (RT-PCR) for their diagnosis and determination of primary origin. Two hundred and twenty-eight malignant (132 male, 96 female) and 185 benign (132 male, 53 female) PEs were investigated. Statistical analyses evaluated the diagnostic performance parameters in all PEs and in cytologically negative malignant PEs, the association between hMAM and benign or malignant status by the direct index of correlation [diagnostic odds ratio (DOR)], χ test, and P value (P). In addition, the discriminative diagnostic power of hMAM expression, independently in breast cancer, lung cancer (LC), malignant mesothelioma (MM), and other cancers was evaluated. In the entire patient population, hMAM was detected in 45.6{\%} and 5.4{\%} of malignant and benign PEs, respectively, in the male group in 41.7{\%} and 4.5{\%} and in the female group in 51.0{\%} and 7.5{\%} of malignant and benign PEs, respectively. A statistically significant correlation between hMAM and malignancy was found in the entire population (DOR=14.68, P",
keywords = "Human mammaglobin, Malignant pleural effusion, Reverse-transcriptase polymerase chain reaction",
author = "Silvio Roncella and Paola Ferro and Franceschini, {Maria Cristiana} and Bartolomeo Bacigalupo and Paolo Dessanti and Massimiliano Sivori and Carletti, {Anna Maria} and Vincenzo Fontana and Canessa, {Pier Aldo} and Pistillo, {Maria Pia} and Franco Fedeli",
year = "2010",
month = "6",
doi = "10.1097/PDM.0b013e3181ba6c78",
language = "English",
volume = "19",
pages = "92--98",
journal = "Diagnostic Molecular Pathology",
issn = "1052-9551",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin

AU - Roncella, Silvio

AU - Ferro, Paola

AU - Franceschini, Maria Cristiana

AU - Bacigalupo, Bartolomeo

AU - Dessanti, Paolo

AU - Sivori, Massimiliano

AU - Carletti, Anna Maria

AU - Fontana, Vincenzo

AU - Canessa, Pier Aldo

AU - Pistillo, Maria Pia

AU - Fedeli, Franco

PY - 2010/6

Y1 - 2010/6

N2 - As was reported that human mammaglobin (hMAM) may be expressed in malignant pleural effusions (PEs), we investigated the relevance of hMAM reverse-transcriptase polymerase chain reaction (RT-PCR) for their diagnosis and determination of primary origin. Two hundred and twenty-eight malignant (132 male, 96 female) and 185 benign (132 male, 53 female) PEs were investigated. Statistical analyses evaluated the diagnostic performance parameters in all PEs and in cytologically negative malignant PEs, the association between hMAM and benign or malignant status by the direct index of correlation [diagnostic odds ratio (DOR)], χ test, and P value (P). In addition, the discriminative diagnostic power of hMAM expression, independently in breast cancer, lung cancer (LC), malignant mesothelioma (MM), and other cancers was evaluated. In the entire patient population, hMAM was detected in 45.6% and 5.4% of malignant and benign PEs, respectively, in the male group in 41.7% and 4.5% and in the female group in 51.0% and 7.5% of malignant and benign PEs, respectively. A statistically significant correlation between hMAM and malignancy was found in the entire population (DOR=14.68, P

AB - As was reported that human mammaglobin (hMAM) may be expressed in malignant pleural effusions (PEs), we investigated the relevance of hMAM reverse-transcriptase polymerase chain reaction (RT-PCR) for their diagnosis and determination of primary origin. Two hundred and twenty-eight malignant (132 male, 96 female) and 185 benign (132 male, 53 female) PEs were investigated. Statistical analyses evaluated the diagnostic performance parameters in all PEs and in cytologically negative malignant PEs, the association between hMAM and benign or malignant status by the direct index of correlation [diagnostic odds ratio (DOR)], χ test, and P value (P). In addition, the discriminative diagnostic power of hMAM expression, independently in breast cancer, lung cancer (LC), malignant mesothelioma (MM), and other cancers was evaluated. In the entire patient population, hMAM was detected in 45.6% and 5.4% of malignant and benign PEs, respectively, in the male group in 41.7% and 4.5% and in the female group in 51.0% and 7.5% of malignant and benign PEs, respectively. A statistically significant correlation between hMAM and malignancy was found in the entire population (DOR=14.68, P

KW - Human mammaglobin

KW - Malignant pleural effusion

KW - Reverse-transcriptase polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=77953166056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953166056&partnerID=8YFLogxK

U2 - 10.1097/PDM.0b013e3181ba6c78

DO - 10.1097/PDM.0b013e3181ba6c78

M3 - Article

C2 - 20502186

AN - SCOPUS:77953166056

VL - 19

SP - 92

EP - 98

JO - Diagnostic Molecular Pathology

JF - Diagnostic Molecular Pathology

SN - 1052-9551

IS - 2

ER -